Article Details

AbbVie Acquires Celsius Therapeutics, Gains Anti-Inflammatory Disease Antibody

Retrieved on: 2024-06-28 16:53:33

Tags for this article:

Click the tags to see associated articles and topics

AbbVie Acquires Celsius Therapeutics, Gains Anti-Inflammatory Disease Antibody. View article details on hiswai:

Excerpt

In March 2024, AbbVie announced it was acquiring Landos Biopharma, a clinical-stage biopharmaceutical company focusing on autoimmune diseases.

Article found on: www.biopharminternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up